EurekaMag
+ Translate
+ Most Popular
Investigations on the organic drift in North Swedish streams
Limitations of Using Microsoft Excel Version 2016 (MS Excel 2016) for Statistical Analysis for Medical Research
Phloem necrosis of coffee in Surinam
Anatomy of Mystus seenghala IV Nervous system
Integrated farming system for gardenland conditions of Coimbatore district - an over view
Tetrapleure (Tetrapleura tetraptera), an unknown African medicinal and spice plant
The origin and phylogenetic significance of the trochophoran larvae 2. evolutionary significance of the larvae of coelomate worms and mollusks
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
Enterobacter amnigenus. An unusual human pathogen
Influence of Seriboost foliar application on leaf yield and leaf protein content in mulberry (Morus spp.), in relation to silkworm cocoon production
The identity of the lipstick mold of cultivated mushrooms agaricus bisporus
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
'Pan-sukh' disease of Rice in the Central Provinces
Geological age of the Ptilophyllum flora; a critical reassessment
Study of vitellogenesis in birds; physiological phases & role of folliculin in vitellogenesis
Evaluation of WCT coconut and Komadan coconut
Therapy for acne with saccharomyces boulardii
Evidence for Late Cretaceous N-S dextral shear in the west-central crystalline core, North Cascades, Washington
'Rajeshwari' - a high-yielding white seeded variety of sesame for Andhra Pradesh
Manufacture of Ricotta cheese from whey fortified with skim milk powder using different acidulants
Occurrence of Eutrichophilus mexicanus (Rudow, 1866) and Eutrichophilus lobatus (Ewing, 1936) (Phthiraptera: Trichodectidae) on Sphiggurus villosus (Cuvier, 1825) (Rodentia: Erethizontidae) in Rio de
Factors affecting fruitfulness in durian (Durio zibethinus Murr.). I. Flowering and pollination
Bronchial cuff pressure change caused by left-sided double-lumen endobronchial tube displacement
Some Biological Applications of Organometallic Compounds
The composition of pampas-grass (Cortaderia argentea.)

Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy


Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy



Aids 16(4): 672-673



ISSN/ISBN: 0269-9370

PMID: 11873014

17 of 574 (3.0%) human immunodeficiency virus (HIV)-infected patients at the National Taiwan University Hospital, Taiwan were diagnosed with penicilliosis marneffei between June 1994 and June 2001. The patients with penicilliosis marneffei were usually treated with amphotericin B at a daily dose of 0.7-1.0 mg/kg for 2 weeks, followed by itraconazole 400 mg a day for 6-8 weeks.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 003714934

Download citation: RISBibTeXText

Related references

Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy. International Journal of Std and Aids 13(10): 702-705, 2002

Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART. Aids 21(3): 365-367, 2007

Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy. Aids 14(16): 2615-2617, 2000

Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy. Aids 15(11): 1448-1449, 2001

Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy. Aids 15(5): 645-647, 2001

Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 34(3): 394-397, 2002

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy. Aids 14(4): 383-386, 2000

Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy. Aids 14(18): 2946-2948, 2000

Successful discontinuation of secondary prophylaxis for histoplasmosis after highly active antiretroviral therapy. Journal of the Formosan Medical Association 103(7): 546-548, 2004

A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98. New England Journal of Medicine 344(3): 159-167, 2001

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 36(10): 1329-1331, 2003

Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 43(1): 79-89, 2006

Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 30(3): 602-603, 2000

Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy. Pediatric Infectious Disease Journal 24(12): 1117-1120, 2005

Discontinuation of maintenance therapy for CMV retinitis in AIDS patients on highly active antiretroviral therapy. Ocular Immunology and Inflammation 7(3-4): 199-203, 1999